Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial.

MLA

Elshafie, Ahmed Hanei, et al. “Ivermectin Role in COVID-19 Treatment (IRICT): Single-Center, Adaptive, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.” Expert Review of Anti-Infective Therapy, vol. 20, no. 10, Oct. 2022, pp. 1341–50. EBSCOhost, https://doi.org/10.1080/14787210.2022.2098113.

APA

Elshafie, A. H., Elsawah, H. K., Hammad, M., Sweed, E. M., Seif, A. S., Abdel Ghaffar, M. M., Goda, F. M., Mosalam, E. M., & Abdallah, M. S. (2022). Ivermectin role in COVID-19 treatment (IRICT): single-center, adaptive, randomized, double-blind, placebo-controlled, clinical trial. Expert Review of Anti-Infective Therapy, 20(10), 1341–1350. https://doi.org/10.1080/14787210.2022.2098113

Chicago

Elshafie, Ahmed Hanei, Hozaifa Khalil Elsawah, Mohamed Hammad, Eman Mohamed Sweed, Ahmed Salah Seif, Muhammad Mostafa Abdel Ghaffar, Feisal Mahmoud Goda, Esraa M Mosalam, and Mahmoud S Abdallah. 2022. “Ivermectin Role in COVID-19 Treatment (IRICT): Single-Center, Adaptive, Randomized, Double-Blind, Placebo-Controlled, Clinical Trial.” Expert Review of Anti-Infective Therapy 20 (10): 1341–50. doi:10.1080/14787210.2022.2098113.